期刊文献+

非酒精性脂肪肝患者发生2型糖尿病危险因素分析 被引量:5

Analysis of risk factors of type 2 diabetes in patients with Nonalcoholic fatty liver disease
在线阅读 下载PDF
导出
摘要 目的探讨非酒精性脂肪肝(NAFLD)患者发生2型糖尿病的危险因素。方法选择38例非酒精性脂肪肝伴初诊2型糖尿病(DFL)患者,并与26例非酒精性脂肪肝(NAFLD)患者进行比较,对两组的相关变量进行多因素Logistic回归分析。结果27个变量中,单因素Logistic回归分析显示糖尿病家族史、体重指数、业余锻炼、婚姻状况、脂肪肝病程、甜食、甘油三酯、载脂蛋白A1、空腹胰岛素、餐后2小时胰岛素、C肽(CP)、胰岛素抵抗指数、空腹血糖、餐后2小时血糖在两组间差异有显著性;多因素Logistic回归分析显示家族关系、业余锻炼、甜食、甘油三酯、载脂蛋白A1、餐后2小时胰岛素、空腹血糖及餐后2h血糖具有统计学意义。结论糖尿病家族史、甜食、高甘油三酯、高载脂蛋白A1及餐后2小时胰岛素降低是非酒精性脂肪肝患者发生2型糖尿病危险因素,而业余锻炼是其保护因素。 Objective To explore risk factors of type 2 diabetes in patients with Nonalcoholic fatty liver disease. Methods The data of 38 cases of Nonalcoholic fatty liver disease with type 2 diabetes were collected in our hospital from 2006.1 to 2008 1,26 cases of Nonalcoholic fatty liver disease were selccteg randomly as control during the same period. The associat- ed variable were analyzed by using logistic regression model. Results Family history, exercise, sugar food, triglycerids (TG) ,APOA1 and 2h insulin had statistic significance. Conclusion Family history, sugar food, high serum triglycerids (TG) ,high serum APOA1 and low 2 h insulin were the main risk factors forming type 2 Diabetes in nonalcoholic fatty liver patients ,while appropriate exercise is a protective factor.
出处 《临床肝胆病杂志》 CAS 2009年第2期129-130,共2页 Journal of Clinical Hepatology
关键词 2型糖尿病 非酒精性脂肪肝 危险因素 LOGISTIC回归分析 type 2 diabetes Nonalcoholic fatty liver disease risk factors logistic regression model
作者简介 作者简介:张金华(1967-),男,医学硕士,副主任医师,主要从事肝胆疾病的临床诊治。
  • 相关文献

参考文献5

二级参考文献12

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2[1]Haffner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the HOMA model. The Mecico city diabetes study. Diabetes Care,1996, 19:1138-1141.
  • 3[2]Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo-Clin-Proc,2000, 75:733-739.
  • 4[3]Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab, 2000, 26 : 98-106.
  • 5[5]Cortez-Pinto-H, Camilo ME, Baptista A, et al. Non-alcoholic fatty liver:another feature of the metabolic syndrome? Clin-Nutr, 1999, 18: 353-358.
  • 6[6]Herranz L, Zapata A, Grande C, et al. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects. Horm Metab Res. 1998, 30:141-145.
  • 7[7]Van-Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int-J-Obes-Relat-Metab-Disord. 1995, 19(Suppl 3):S27-36.
  • 8[8]Pares A, Tresserras R, Nunez I, et al. Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men. Med-ClinBarc. 2000,114:561-565.
  • 9Wolfrum C,Borrmann CM,Borchers T,et al.Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha-and gamma-mediated gene expression via liver fatty acid binding protein:a signaling path to the nucleus.Proc Natl Acad Sci U S A,2001,98:2323-2328.
  • 10Ugawa T,Kakuta H,Moritani H,et al.M-53601,a novel squalene synthase inhibitor,reduces plasma cholesterol and triglyceride levels in several animal species.Br J Pharmacol,2000,131:63-70.

共引文献1424

同被引文献45

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部